Best TWAS P=5.38e-13 · Best GWAS P=2.06e-14 conditioned to 0
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | FLG | 0.75 | 0.44 | enet | 31 | 0.61 | 3.8e-95 | -5.92 | -5.9 | 4.5e-09 | -0.07 | 0.99 | 0.01 | TRUE |
2 | CommonMind | Brain Pre-frontal Cortex | FLG2 | 0.68 | 0.35 | bslmm | 396 | 0.44 | 1.0e-58 | -5.92 | -5.4 | 6.2e-08 | -0.05 | 0.99 | 0.01 | FALSE |
3 | GTEx | Colon Sigmoid | S100A11 | 0.18 | 0.13 | lasso | 3 | 0.14 | 1.1e-05 | 6.55 | 7.2 | 5.4e-13 | 0.55 | 0.21 | 0.08 | TRUE |
4 | GTEx | Colon Sigmoid | TDRKH | 0.28 | 0.20 | enet | 16 | 0.17 | 1.2e-06 | -3.76 | -5.9 | 3.1e-09 | -0.26 | 0.90 | 0.04 | FALSE |
5 | METSIM | Adipose | FLG | 0.19 | 0.15 | lasso | 7 | 0.15 | 4.3e-22 | -6.01 | -5.7 | 1.5e-08 | -0.25 | 0.98 | 0.02 | FALSE |
6 | The Cancer Genome Atlas | Breast Invasive Carcinoma | LINGO4 | 0.15 | 0.03 | lasso | 4 | 0.05 | 8.9e-10 | 7.31 | 5.4 | 5.8e-08 | 0.44 | 0.00 | 1.00 | TRUE |
7 | The Cancer Genome Atlas | Colon Adenocarcinoma | LINGO4 | 0.29 | 0.07 | enet | 15 | 0.07 | 8.3e-05 | 7.31 | 7.2 | 5.8e-13 | 0.38 | 0.00 | 0.98 | TRUE |
8 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | HRNR | 0.04 | 0.03 | lasso | 1 | 0.02 | 2.9e-03 | -6.01 | 6.0 | 1.9e-09 | 0.26 | 0.01 | 0.87 | FALSE |
9 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | LINGO4 | 0.22 | 0.06 | enet | 13 | 0.06 | 3.3e-07 | 7.31 | 5.3 | 1.5e-07 | 0.46 | 0.00 | 1.00 | TRUE |
10 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | HRNR | 0.25 | 0.17 | lasso | 7 | 0.17 | 4.3e-10 | -6.01 | 6.0 | 1.6e-09 | 0.25 | 0.00 | 1.00 | TRUE |
11 | The Cancer Genome Atlas | Brain Lower Grade Glioma | SMCP | 0.26 | 0.05 | enet | 13 | 0.09 | 1.4e-10 | 0.27 | 5.6 | 2.6e-08 | 0.03 | 0.07 | 0.88 | TRUE |
12 | The Cancer Genome Atlas | Lung Adenocarcinoma | LINGO4 | 0.20 | 0.07 | lasso | 4 | 0.07 | 3.7e-08 | 7.31 | 6.7 | 1.8e-11 | 0.53 | 0.00 | 1.00 | FALSE |
13 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | HRNR | 0.62 | 0.11 | lasso | 7 | 0.14 | 1.1e-06 | -5.49 | 5.9 | 4.8e-09 | 0.28 | 0.01 | 0.99 | TRUE |
14 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | LINGO4 | 0.32 | 0.09 | lasso | 8 | 0.13 | 3.3e-06 | 7.31 | 6.9 | 3.9e-12 | 0.46 | 0.00 | 0.99 | TRUE |
15 | The Cancer Genome Atlas | Prostate Adenocarcinoma | LINGO4 | 0.53 | 0.20 | lasso | 4 | 0.23 | 1.1e-23 | 7.31 | 5.7 | 9.2e-09 | 0.49 | 0.00 | 1.00 | TRUE |
16 | The Cancer Genome Atlas | Soft Tissue Sarcoma | HRNR | 0.17 | 0.10 | blup | 50 | 0.10 | 1.1e-06 | -6.01 | 5.5 | 3.0e-08 | 0.32 | 0.00 | 0.99 | TRUE |
17 | The Cancer Genome Atlas | Thyroid Carcinoma | LINGO4 | 0.43 | 0.15 | lasso | 7 | 0.20 | 2.3e-19 | 7.31 | 5.2 | 1.8e-07 | 0.44 | 0.00 | 1.00 | FALSE |